IR-Med 배당금

배당금 기준 확인 0/6

IR-Med does not have a record of paying a dividend.

주요 정보

n/a

배당 수익률

-2.0%

환매 수익률

총 주주 수익률	-2.0%
미래 배당 수익률	n/a
배당금 성장	n/a
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	n/a
지급 비율	n/a

최근 배당금 업데이트

업데이트 없음

Recent updates

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: Insufficient data to determine if IRME's dividends per share have been stable in the past.

배당금 증가: Insufficient data to determine if IRME's dividend payments have been increasing.

시장 대비 배당 수익률

IR-Med 시장 대비 배당 수익률

IRME 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (IRME)	n/a
시장 하위 25% (US)	1.5%
시장 상위 25% (US)	4.5%
업계 평균 (Medical Equipment)	1.7%
애널리스트 예측 (IRME) (최대 3년)	n/a

주목할만한 배당금: Unable to evaluate IRME's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

고배당: Unable to evaluate IRME's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

주주에 대한 수익 배당금

수익 보장: Insufficient data to calculate IRME's payout ratio to determine if its dividend payments are covered by earnings.

주주에 대한 현금 배당금

현금 흐름 범위: Unable to calculate sustainability of dividends as IRME has not reported any payouts.

IR-Med 배당금

배당금 기준 확인 0/6

주요 정보

최근 배당금 업데이트

Recent updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

IR-Med Inc. has filed an IPO in the amount of $8 million.

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc.’s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Hmo

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

IR-Med Inc., Annual General Meeting, Dec 12, 2022

IR-Med Announces Appointment of Moshe Gerber as Chief Executive Officer

International Display Advertising, Inc. (OTCPK:IDAD.D) completed the acquisition of IR Med, Ltd.

International Display Advertising, Inc. announced that it expects to receive $5 million in funding

결제의 안정성과 성장

시장 대비 배당 수익률

주주에 대한 수익 배당금

주주에 대한 현금 배당금

강력한 배당금 지급 기업 알아보기